# BioRexis Pharmaceuticals Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biorexis-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: King of Prussia, US
- Total disclosed funding: $38M
- Latest round: Series B (Mar 1, 2004)
- Investors on record: 7

## About

BioRexis Pharmaceuticals Corporation, is based in King of Prussia, US and is a biopharmaceutical company, develops and produces biopharmaceuticals.

## Funding rounds

- Series B, Mar 1, 2004, $30M — Prism Venture Management, Tullis Health Investors, Quaker Partners Management, Anthem Capital, Johnson & Johnson Innovation, ProQuest Investments, Gund Investment Corporation
- Series A, Dec 19, 2002, $8M — Tullis Health Investors, Quaker Partners Management, ProQuest Investments

## Investors

- Tullis Health Investors (https://capitalatlas.ai/funds/tullis-health-investors) — Series A, Series B
- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Series A, Series B
- ProQuest Investments (https://capitalatlas.ai/funds/proquest-investments) — Series A, Series B
- Prism Venture Management (https://capitalatlas.ai/funds/prism-venture-management) — Series B
- Anthem Capital (https://capitalatlas.ai/funds/anthem-capital) — Series B
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series B
- Gund Investment Corporation — Series B